Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 3/2012

01-03-2012 | General Gynecology

Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Login to get access

Abstract

Objective

Polycystic ovarian syndrome is one of the most frequent endocrine dysfunctions in women in their fertile age. To date, a clear definition of the disease remains controversial among experts, partly because study results concerning diagnostics and therapy are incoherent. In this survey, we intend to give an insight into the diagnostics and treatment regimes of PCOS in Germany and subsequently compare these results to the current recommendations found in international literature.

Design

In 2005, 7,000 outpatient gynecologists received a questionnaire with questions on PCOS definition, diagnostics and treatment.

Results

The survey shows that it remains difficult for gynecologists to restrict themselves to the few definition criteria defined in the 2003 Rotterdam PCOS Consensus Workshop. Nevertheless, therapy and diagnosis of PCOS show a uniform treatment pattern. The current recommendations found in international literature have been widely implemented into clinical practice. Modern therapeutic approaches such as the use of metformin are increasingly acknowledged.

Conclusion

Further studies dealing with the diagnosis and therapy of PCOS will be necessary in order to establish guidelines, especially when looking at patients without a desire for reproduction.
Appendix
Available only for authorised users
Literature
1.
2.
Hart R, Hickey M, Franks S (2004) Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:671–683PubMedCrossRef
3.
Matalliotakis I, Kourtis A, Koukoura O, Panidis D (2006) Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet 274:187–197PubMedCrossRef
4.
ESHRE Rotterdam/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef
5.
Laven JSEM, Imani B, Eijkemans MJC, Fauser BCJM (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755–767PubMedCrossRef
6.
Fraser IS, Kovacs G (2004) Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:813–823PubMed
7.
Lakhani K, Seifalian AM, Atiomo WU, Hardiman P (2002) Polycystic ovaries. Br J Radiol 75:9–16PubMed
8.
Taylor AE, McCourt B, Martin KA et al (1997) Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248–2256PubMedCrossRef
9.
Pasquali R, Antenucci D, Casimirri F et al (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68:173–179PubMedCrossRef
10.
Kiddy DS, Hamilton-Fairley D, Bush A et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105–111CrossRef
11.
Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255–1260PubMedCrossRef
12.
Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191
13.
Silfen ME, Denburg MR, Manibo AM et al (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682–4688PubMedCrossRef
14.
Moran L, Norman RJ (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:719–736PubMedCrossRef
15.
Talbott E, Guzick D, Clerici A et al (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821–826PubMedCrossRef
16.
Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165–169PubMedCrossRef
17.
Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L (2002) Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 25:1217–1222PubMedCrossRef
18.
19.
Elsenbruch S, Hahn S, Kowalsky D et al (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801–5807PubMedCrossRef
20.
Cattrall FR, Healy DL (2004) Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:803–812PubMedCrossRef
21.
22.
Archer JS, Chang RJ (2004) Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:737–754PubMedCrossRef
23.
Schüring AN, Kiesel L (2005) Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS). Gynäkologe 38:333–341CrossRef
24.
Graf M (2006) CME Praktische Fortbildung—Gynäkologie, Geburtsmedizin und Gynäkologische Endokrinologie, akademos Wissenschaftsverlag, Hamburg, Germany 3
25.
Dahlgren E, Landin K, Krotkiewski M, Holm G, Janson PO (1998) Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 13:2706–2711PubMed
26.
27.
Palombo-Kinne E, Schellschmidt I, Schumacher U, Graser T (2009) Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate. Contraception 79:282–289PubMedCrossRef
28.
Saleh AM, Khalil HS (2004) Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 83:614–621PubMed
29.
Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynecol 18(5):773–788CrossRef
30.
Al-Azemi M, Omu FE, Omu AE (2004) The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 270:205–210PubMedCrossRef
31.
Clark AM, Ledger W, Galletly C et al (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705–2712PubMed
32.
Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G (2003) Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18:1928–1932PubMedCrossRef
33.
Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:773–788PubMedCrossRef
34.
Muth S, Norman J, Sattar N, Fleming R (2004) Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Hum Reprod 19:2718–2720PubMedCrossRef
35.
Kelly CJ, Gordon D (2002) The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol 147:217–221PubMedCrossRef
36.
Hahn S, Quadbeck B, Elsenbruch S et al (2004) Metformin, an efficacious drug in the treatment of polycystic ovary syndrome. Dtsch Med Wochenschr 129:1059–1064PubMedCrossRef
37.
Harborne L, Fleming R, Lyall H, Sattar N, Norman J (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88:4116–4123PubMedCrossRef
38.
Lam PM, Cheung LP, Haines C (2004) Revisit of metformin treatment in polycystic ovarian syndrome. Gynecol Endocrinol 19:33–39PubMedCrossRef
39.
Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev (1). Report. doi:10.​1002/​14651858.​CD003053.​pub4
40.
Bühling KJ, Bartley J, Lübbert H (2006) Einsatz oraler Antidiabetika in der Therapie des Kinderwunsches, des Gestationsdiabetes und zur Prävention des Typ-2- Diabetes. Geb Fra 66:1–5
41.
De Leo V, la Marca A, Ditto A, Morgante G, Cianci A (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72:282–285PubMedCrossRef
42.
Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876–1880PubMedCrossRef
43.
Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77:209–215PubMedCrossRef
44.
Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068–4074PubMedCrossRef
45.
Tan SL, Farhi J, Homburg R, Jacobs HS (1996) Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH. Obstet Gynecol 88:221–226PubMedCrossRef
46.
Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 105:338–344PubMedCrossRef
47.
Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361–2365PubMedCrossRef
48.
Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P (2005) Laparoscopic “drilling” by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev CD001122
49.
Verhelst J, Gerris J, Joostens M, Van der Meer S, Van Royen E, Mahler C (1993) Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease. Gynecol Endocrinol 7:49–55PubMedCrossRef
50.
Farhi J, Soule S, Jacobs HS (1995) Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 64:930–935PubMed
Metadata
Title
Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature
Publication date
01-03-2012
Published in
Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2014-7

Other articles of this Issue 3/2012

Archives of Gynecology and Obstetrics 3/2012 Go to the issue

Gynecologic Oncology

Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas

Maternal-Fetal Medicine

Association of placental inflammation with fetomaternal hemorrhage and loss of placental mucin-1

General Gynecology

Biomechanics of the female pelvic floor: a prospective trail of the alteration of force–displacement-vectors in parous and nulliparous women

Gynecologic Oncology

Cervical sarcoma botryoides and ovarian Sertoli–Leydig cell tumor: a case report and review of literature

General Gynecology

A case with vesicouterine fistula: mini review

Gynecologic Oncology

Prevalence and risk factors of HPV infection among women from various provinces of the world